- Entry
- $3.38
- Now
- $2.94 -13.0%
- Target
- —
- Score
- —
**Transformative stage for NRx.** **Note:** In creating this post a msg appeared saying "you may not have 'free' cannot be in the title," so I used "no-preservative," when the common terminology is "preservative-free." SP $3.50 | MC $152M | OS 43.3M If you want a good company to buy, which is highly derisked for an approval in the near term, NRx is an excellent opportunity. **Current ketamine issues to be solved:** * Ketamine is on the FDA shortage list. * …
— ORIGINAL POST ·
NRx Pharmaceuticals (NRXP) - Awaiting ANDA (generic drug) approval for no-preservative Intravenous (IV) ketamine for analgesia (pain control) and anesthesia ... which will happen in the near term.
· r/pennystocks
· Aug 21, 2026